SARS-CoV-2 variants evolve convergent strategies to remodel the host response

Authors:
  • MBMehdi Bouhaddou
    Mehdi Bouhaddou

Abstract
No abstract available
Funding Information
  • National Institutes of Health (U19AI135990)
  • National Institutes of Health (U19AI171110)
  • National Institutes of Health (U19AI135972)
  • National Institutes of Health (133122P)
  • National Institute of Allergy and Infectious Diseases (75N93021C00014)
  • F. Hoffmann-La Roche
  • Pfizer
  • Senhwa Biosciences
  • Merck
  • Vir Biotechnology